Contact
I'd love to hear from you!
Email me
Questions & Answers
What specific consulting services do you offer?
I specialize in Health Economics (HEOR), Global Market Access Strategy, AI-driven Predictive Modeling, and Clinical Trial Design. I help organizations translate complex data into evidence-based decisions for product launches and policy shaping.
Do you work with startups or large pharmaceutical companies?
I collaborate with both. My experience ranges from managing $15M portfolios for global pharma leaders like Sanofi to advising emerging healthcare startups on go-to-market strategies and MVP development.
How does your AI expertise add value to clinical research?
I apply machine learning and predictive modeling to unstructured datasets (like genomic or clinical data). This approach has helped achieve >90% predictive accuracy in disease risk models and reduced diagnostic costs by up to 60%.
Can you support global market access strategies?
Yes. I have extensive experience designing market access and reimbursement strategies across key international markets, including the U.S., EU, LATAM, and Asia, ensuring regulatory alignment and successful product adoption.
What is your approach to evidence generation?
My approach is data-driven and patient-centric. I utilize Real-World Evidence (RWE), patient-reported outcomes (like FD-PRO), and economic modeling to generate robust data that supports payer negotiations and regulatory approvals.